Table 1.
Event | No. patients in STRIDE | No. patients in PAMF | No. positive test cases |
---|---|---|---|
Total | 565 998 | 969 511 | 849 |
Cardiac arrhythmias | 88 555 | 109 601 | 65 |
Acute renal failure | 32 197 | 28 994 | 15 |
Bradycardia | 22 906 | 24 162 | 52 |
Hyperglycemia | 19 189 | 41 574 | 47 |
Neutropenia | 14 322 | 6783 | 13 |
Hypoglycemia | 11 150 | 28 320 | 43 |
Pancytopenia | 8718 | 2850 | 2 |
Hypokalemia | 8405 | 10 356 | 44 |
Hyperkalemia | 4973 | 7691 | 142 |
Parkinsonian symptoms | 3541 | 4605 | 9 |
Nephrotoxicity | 1460 | 639 | 83 |
Rhabdomyolysis | 1378 | 1948 | 30 |
QT prolongation | 1260 | 1441 | 150 |
Serotonin syndrome | 674 | 1511 | 154 |
We consider 14 adverse events for our study; our gold standard contains a total of 849 positive test cases and 849 randomly generated negative test cases.
PAMF, Palo Alto Medical Foundation; STRIDE, Stanford Translational Research Integrated Database Environment.